Craig Hopkinson
Equibles does not estimate personal net worth.
Get an email with a short summary when Alkermes plc. publishes a filing, an earnings call transcript or a press release.
Get ALKS alertsAbout Craig Hopkinson
The proxy statement of Alkermes plc. reports total compensation of $3,617,908 for Craig Hopkinson in fiscal 2025, including a base salary of $764,837. Disclosed compensation is on record for 8 fiscal years. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.
Affiliation history
-
Alkermes plc. (ALKS)
Proxy statement
CurrentStart not stated–present
Last confirmed April 6, 2026
Company network
Leadership on record at Alkermes plc.
- Blair C. Jackson CEO, CFO, COO
- Mr. Richard F. Pops CEO
- Iain M. Brown CFO, Chief Accounting Officer
- Blair Jackson COO
- James A. Robinson COO
- Samuel J. Parisi Chief Accounting Officer
- Andy Wilson Board Member
- Anne C. Whitaker Board Member
- Brian McKeon Board Member
- Brian P. McKeon Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $764,837 | $3,617,908 |
| 2024 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $742,560 | $4,343,991 |
| 2023 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $714,000 | $4,226,388 |
| 2022 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $693,000 | $4,546,920 |
| 2021 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $670,000 | $4,727,478 |
| 2020 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $650,000 | $3,957,135 |
| 2019 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $621,000 | $3,656,337 |
| 2018 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $600,000 | $3,791,198 |
Recent activity
No call appearances or filed executive changes recorded yet.